Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
Construct a sophisticated document retrieval pipeline that dynamically injects client data into LLM context windows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results